Physician profile
Jason Nemitz
NPI 1871703488
$4,184.61
in general payments reported to CMS, 2019-2025
12 companies · $1,521 in 2025
The $1,521 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $211 · 2021: $289 · 2022: $958 · 2023: $242 · 2024: $768 · 2025: $1,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,446 · Long Term Medical Supply Or Device Loan: $84.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,446.30 |
| Long Term Medical Supply Or Device Loan | $84.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,619.03 | 2019-2025 | Variax, Pangea, Axsos |
| Bioventus LLC | $125.74 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $120.10 | 2025 | |
| Baxter Healthcare | $84.71 | 2023 | |
| Next Science LLC | $70.55 | 2021 | |
| Organogenesis INC. | $35.20 | 2024 | |
| Zimmer Biomet Holdings, INC. | $34.36 | 2019 | |
| Heron Therapeutics, INC. | $23.55 | 2022 | |
| Coastal Medical Technologies LLC | $22.90 | 2024 | |
| Radius Health, INC. | $18.30 | 2020 | |
| Orthogenrx INC. | $17.07 | 2019 | |
| Amgen INC. | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Nemitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.